1. In Vivo
  2. >>Outlook
  3. >>Outlook Archive

Big Three Lead From The Front With Medtech Back On Solid Growth Footing

Most Of The Medtech Top 10 Got Back To Winning Ways On Revenues With Some Unexpected Exceptions

 
• By Ashley Yeo

Abbott Laboratories and Johnson & Johnson joined Medtronic in putting a clear distance between themselves and other global medtechs in the Top 10 by revenues for 2021. Post-COVID-19 procedure growth, and, for Abbott, a strong rebound in non-COVID diagnostic demand, were key drivers.  

Mountain climbing
• Source: Shutterstock

Abbott Laboratories joined Medtronic in recording more than $30bn in revenues In 2021, the first year that the medical devices and diagnostic industries have had two companies exceeding this threshold.

In the next year or two, Johnson & Johnson might also join the club if it consolidates progress made in putting on almost 18% more revenues in 2021 to reach $27.1bn

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Outlook Archive

More from Outlook